By Denny Jacob BeautyHealth Chief Executive Andrew Stanleick is leaving the company. The company, which manufactures and sells serum-based products, said.
The BeautyHealth Co. has initiated a stock repurchase program. The $100 million program is part of a transformation drive at the Long Beach-based skincare products manufacturer to drive profitable growth by reducing operating costs and streamlining its operations.